Cervical Glandular Neoplasia: Classification and Staging

Surg Pathol Clin. 2019 Jun;12(2):281-313. doi: 10.1016/j.path.2019.01.002.

Abstract

Endocervical adenocarcinomas (EAs) account for 25% of all primary cervical carcinomas. Approximately 85% of EAs are driven by high-risk human papillomavirus (HPV) infection, the most common of which is the so-called usual type endocervical adenocarcinomas. Non-HPV-driven subtypes harbor distinct clinicopathologic features and prognosis and have been increasingly recognized in recent years, which has led to efforts to improve classification of EA based on clinically relevant and reproducible criteria. This review discusses a recently proposed classification system, the International Endocervical Adenocarcinoma Criteria and Classification, which uniquely integrates morphology, cause/pathogenesis, and biological behavior of HPV and non-HPV-driven subtypes of EA.

Keywords: Cervical adenocarcinoma; Classification; Human papillomavirus; Staging.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / classification*
  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / etiology
  • Adenocarcinoma / pathology
  • Adenocarcinoma, Mucinous / classification
  • Adenocarcinoma, Mucinous / diagnosis
  • Adenocarcinoma, Mucinous / etiology
  • Adenocarcinoma, Mucinous / pathology
  • Female
  • Humans
  • Neoplasm Staging
  • Papillomavirus Infections / complications
  • Prognosis
  • Uterine Cervical Neoplasms / classification*
  • Uterine Cervical Neoplasms / diagnosis
  • Uterine Cervical Neoplasms / etiology
  • Uterine Cervical Neoplasms / pathology